iovera

iovera° uses the body's natural response to cold to provide immediate #opioid-free #kneepain relief for up to 90 days for post-op #kneereplacement.

[AlliedPain @AlliedPainOrtho]

Iovera° treatment uses the body’s natural response to pressurized liquid nitrous oxide to instantaneously reduce #pain without disrupting surrounding tissue.

We use this for a wide range of conditions such as occipital neuralgia, TMJ & #kneepain

#APSI
https://t.co/HUfdkvGSHs

[iovera @iovera]

#ICYMI @Medtech_Insight reporter @medtechMarion interviewed 🗣️ William Mihalko, MD, PhD @CampbellClinic @UTHSC about the new iovera data he presented at #AAOS2019.

Check it out here: https://t.co/zEGzDAHYzD

[iovera @iovera]

Shout-out 📣 to the iovera experts👨‍⚕️ at our #AAOS2019 booth who answered Qs & shared their knowledge of how iovera has made a difference in the lives of their knee surgery patients🦵. Thank you Drs. Joshua Urban, Vinod Dasa, Nirav Amin & Scott Sigman. https://t.co/E3oIv9heQi

[iovera @iovera]

iovera is FDA-cleared to provide fast, immediate opioid-free pain relief for up to 90 days. It safely & effectively freezes nerves while protecting surrounding tissue, & uses the body’s natural response to cold to immediately block sensory nerves from sending pain signals. Watch:

[iovera @iovera]

"This trial represents our commitment to developing innovative technologies that offer a safe & reliable option for people suffering from chronic knee pain" -CEO Tim Still.

At #AAOS2019, we shared new data on how iovera reduces opioid use & pain post-TKA: https://t.co/JI2MaeZLJg

[iovera @iovera]

President & CEO Tim Still to @Ryortho1 on #AAOS2019 & our new #iovera ❄️ Smart Tip: “The opportunity to share our positive data with the clinical community directly following the announcement of our agreement with #Pacira has been really exciting for us." https://t.co/ep7PJq4y0I

[iovera @iovera]

For all you want to know about the #Pacira-#Myoscience agreement, read @Wendydiller's perspective in @MedTechStrat on how we're tackling the #opioid epidemic together using #iovera with EXPAREL for a non-opioid multimodal regimen for effective pain relief: https://t.co/lugiBibi3E

[iovera @iovera]

Our president & CEO Tim Still spoke to @Medgadget about the #iovera system & the positive clinical data we recently presented at #AAOS2019, demonstrating reduced use of #opioids & reduced pain for patients after TKA 🦵 surgery. #Myoscience

Read it here: https://t.co/5YVFZM2f9i

[iovera @iovera]

Our iovera cryotherapy puts pain on ice ❄️ with our Smart Tip technology ⬇️

The new Smart Tip 309 includes longer tips that produce larger cold zones 🌨️ to safely & effectively treat the genicular nerves of the knee 🦵 in a broader patient population: https://t.co/qnPfHFD41S

[iovera @iovera]

William Mihalko, MD, PhD presented new data supporting iovera ❄️ as an effective alternative to opioids post-TKA🦵

"Cryoneurolysis with the iovera system has made a measurable impact on pain relief, reduced patients’ use of opioids after surgery & improved overall knee function"

[iovera @iovera]

#ICYMI Our team showcased the new iovera Smart Tip @ #AAOS2019.

This features longer probes to deliver precise & controlled doses of cold ❄️ to freeze peripheral nerves, producing an immediate & long-lasting nerve block for pain relief. See how it works: https://t.co/126BwuKUF7

[iovera @iovera]

It was great to exhibit the new #iovera Smart Tip at #AAOS2019! The new Smart Tip has longer needles, which produce larger cold zones ❄️ and allows for the treatment of superficial nerves in a larger patient population.

[iovera @iovera]

"The combination of iovera & Exparel serves as a really complementary solution for better managing pain after surgery & reduces, even eliminates use of opioids,"-CEO Tim Still to @fwmedtech on the benefit for patients receiving #iovera & our deal w/Pacira: https://t.co/khgFdN1CCH

[iovera @iovera]

#AAOS2019: Cryoneurolysis ❄️ w/ #iovera prior to TKA showed reduced use of #opioids 💊 & pain post-op.

"There were 3-times more subjects in the control group using opioids at the 6-week mark. That was 46% vs.16% of the [iovera] treatment group" @GoHealio https://t.co/9tk8oy62UE

[iovera @iovera]

That’s a wrap for #AAOS2019! Thanks to all who attended the Innovation Theater presentation and visited our #iovera booth to check out the new iovera Smart Tip and chill with us ❄️

[Marion Webb @medtechMarion]

Dr. William Milhalko presented Iovera pain relief system freezing nerves prior to surgery; findings showed 35% reduc in overall narcotic use; 46% of patients used narcotics at 6 wks following surgery vs 14% of patients on Iovera; #AAOS2019

[iovera @iovera]

Immediate, #opioid-free pain relief for post-op #kneepain? 💡

Visit us at #AAOS2019 booth 4258 to see how the iovera° system safely & effectively freezes both superficial + deep nerves in the knee. https://t.co/LzMo1EhqJJ

[Tina Tan @MedtechTinaTan]

Just been catching up with .@myoscience CEO Tim Still. Chatted about Pacira deal, expected to close by April. Still said no real rivals to #cryoneurolysis treatment that #iovera offers. Sales currently focused on US; CE mark/Canda approve by year-end #AAOS2019

[iovera @iovera]

Our president & CEO Tim Still is at #AAOS2019 this week talking the latest about #iovera and the agreement with Pacira. Visit us at booth #4258!

https://t.co/FaepSa80Nr

[Tina Tan @MedtechTinaTan]

Just been catching up with .@myoscience CEO Tim Still. Chatted about Pacira deal, expected to close by April. Still said no real rivals to #cryoneurolysis treatment that #iovera offers. Sales currently focused on US; CE mark/Canda approve by year-end #AAOS2019

[iovera @iovera]

Cryoanalgesia: A Path to an #Opioid-Free TKA, Pre-op ➡️ Rehab @ #AAOS2019, Innovation Theater, 3.13 @ 2:15.

STARTING SOON: @CampbellClinic's Dr. Mihalko will present prelim. data on iovera for ⏬ opioid use for post-op knee replacement pain https://t.co/70cgZKMcUz